These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 28577884)

  • 1. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
    Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
    Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
    Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
    Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Venkatesh KK; Clark LH; Stamilio DM
    Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
    Cadish LA; Shepherd JP; Barber EL; Ridgeway B
    Am J Obstet Gynecol; 2017 Nov; 217(5):603.e1-603.e6. PubMed ID: 28619689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.
    Kwon JS; McAlpine JN; Hanley GE; Finlayson SJ; Cohen T; Miller DM; Gilks CB; Huntsman DG
    Obstet Gynecol; 2015 Feb; 125(2):338-345. PubMed ID: 25568991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.
    Subramaniam A; Einerson BD; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
    Gynecol Oncol; 2019 Jan; 152(1):127-132. PubMed ID: 30477808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer.
    Tai RWM; Choi SKY; Coyte PC
    J Obstet Gynaecol Can; 2018 Mar; 40(3):317-327. PubMed ID: 29054509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
    Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Laparoendoscopic Single-site Surgical Approach to Laparoscopic Salpingectomy.
    Scheib SA
    J Minim Invasive Gynecol; 2018 Feb; 25(2):326-327. PubMed ID: 28342812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tips and Tricks for Performing Salpingectomy at the Time of Laparoscopic Hysterectomy.
    Stuparich MA; Lee TTM
    J Minim Invasive Gynecol; 2017 Feb; 24(2):205. PubMed ID: 27956107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
    van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini-Laparoscopy for Removal (Partial) of Adnexae at the Time of Hysterectomy.
    Setúbal AG; Alves JS; Lavado O; Faria J
    J Minim Invasive Gynecol; 2017 Feb; 24(2):201-202. PubMed ID: 27856389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
    Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of prophylactic salpingectomy during vaginal hysterectomy.
    Antosh DD; High R; Brown HW; Oliphant SS; Abed H; Philip N; Grimes CL
    Am J Obstet Gynecol; 2017 Nov; 217(5):605.e1-605.e5. PubMed ID: 28734829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?
    Catanzarite T; Eskander RN
    Female Pelvic Med Reconstr Surg; 2020 Jun; 26(6):401-406. PubMed ID: 31135579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer risk reduction through opportunistic salpingectomy.
    Kwon JS
    J Gynecol Oncol; 2015 Apr; 26(2):83-6. PubMed ID: 25872888
    [No Abstract]   [Full Text] [Related]  

  • 17. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Hanley GE; McAlpine JN; Pearce CL; Miller D
    Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.